Events

Innovative Health Initiative - Info session to prepare for IHI Call 9
OCT
Thu
10
10:30 - 11:30

This was 1 year ago

Location

Online

Programmes
Health

For IHI call 9, the Innovative Health Initiative (IHI) will pilot a novel, applicant-driven approach to the call. 

To help potential applicants prepare for the call IHI is organising an online info session with the aim to:

  • present the scope of IHI's next call for proposals;

  • demonstrate how to use the new brokerage platform to create a personal profile, publish project proposals, and search for both potential partners and interesting proposals;

  • describe how to apply to deliver a pitch and present a poster at the brokerage event., which will follow on 12 & 13 november.


More information and registration on the IHI website.
The event will be recorded and the slides and recording will be published here. Registration is free but obligatory.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.